Palantir, U.K. in Talks to License Software for Covid Tracing

Palantir  (PLTR) – Get Report and U.K. officials are in talks to license the data-analytics company’s software to help the country’s effort to trace covid-19 contact during a second wave of the coronavirus, a media report says.

Sources told the Financial Times that test-and-trace officials in the U.K. government have talked about using Palantir’s Foundry software to manage sensitive contact-tracing data.

The aim would be to secure far deeper insights about the way the virus is spreading, so the government can act more quickly.

“The contract would help rationalize the vast trove of information about new virus cases around England, and potentially allow new modeling to track the spread of the disease through particular sectors or parts of the country,” the FT reported.

The U.K. has confirmed more than 1 million coronavirus cases and 47,340 people have died from the disease, the latest data from Johns Hopkins show. 

Read More

Palantir building COVID-19 vaccine allocation tool for US authorities: WSJ

  • Secretive data-analytics company Palantir is developing a system to help local authorities decide where to allocate COVID-19 vaccines, the Wall Street Journal reported.
  • The system is called Tiberius, and is named after Captain Kirk from the “Star Trek” franchise.
  • A document seen by the Journal said Tiberius will analyze “demographic, employment, and public health data” to aid local officials in deciding high-priority populations to vaccinate.
  • Palantir, cofounded by Silicon Valley mogul and vocal Trump-supporter Peter Thiel, has come under fire from human rights groups in the past for its contracts with the US government.
  • Visit Business Insider’s homepage for more stories.

Data-analytics firm Palantir, which has drawn fire from human rights groups for its US government contracts, is reportedly working on a tool to help local authorities decide where to distribute COVID-19 vaccines.

The Wall Street Journal reported the news on Thursday, citing state and local health officials briefed on

Read More

Big data firm Palantir working with US on vaccine effort

Big data company Palantir is working with US health officials on a project to track the production and distribution of future Covid-19 vaccines.

The project first reported by the Wall Street Journal and confirmed by AFP, would use data science to help manage the deployment of any vaccines.

Palantir, which has drawn fire for its police and homeland security projects and for one of its founders’ close ties to President Donald Trump, did not comment on the report.

The Journal reported that the software system with the code name Tiberius could help identify high-priority populations at highest risk of infection but that the deal could draw fire by allowing the private company access to sensitive health information.

At least one pharmaceutical firm has indicated it will seek authorization for a vaccine in the US in November.

Palantir, which last month listed shares on the New York Stock Exchange, has defended

Read More

Pick Palantir Over Snowflake?

[Updated 10/22/2020] Snowflake Vs. Palantir

The last month saw Palantir (NYSE: PLTR) and Snowflake (NYSE: SNOW) – two relatively high profile software players go public. Snowflake’s software enables organizations to manage and analyze large quantities and diverse types of data across public clouds such as Amazon’s AWS in a single, easy to use platform. Palantir offers big data and analytics solutions primarily used by governments and intelligence agencies, although it has been expanding its presence in the commercial space.

While the two companies are focused on big data, investors are valuing them very differently. Snowflake stock trades at over 120x projected FY’21 Revenues (FY ends January) while Palantir trades at just about 15x projected FY’20 Revenues (FY end

Read More